All adults aged 50 years and above are eligible for free flu jabs in England under the autumn Covid-19 booster programme, the Department of Health and Social
Care (DHSC) has announced.
"The flu virus could also be highly infectious at this time of year, so I am also announcing that those eligible for a free flu vaccination this year will include
everyone aged 50 and over, primary school children and secondary school pupils in years 7, 8 and 9, as well as people in clinical risk groups, unpaid carers and
household contacts of those who are immunosuppressed," said new health secretary Steve Barclay.
Commenting on the DHSC's announcement, CCA chief executive Malcolm Harrison said: "We welcome the decision to accept the advice of the JCVI on who can have free
Covid-19 boosters and flu jabs this autumn. Community pharmacies have turbo-charged the Covid-19 vaccination programme over the past 18 months and last year we
witnessed the most successful community pharmacy flu campaign ever."
The Pharmaceutical Services Negotiating Committee (PSNC) has initiated the process for the regional representative election for the North-East and Cumbria
region after Mark Burdon's resignation from the committee earlier this year.
The North-East and Cumbria region covers Community Pharmacy County Durham, Community Pharmacy Cumbria, Gateshead and South Tyneside LPC, North of Tyne LPC,
Sunderland LPC and Tees LPC.
PSNC said that Pharmacists who are independent chemists and members or officers of these LPCs are eligible to stand for election as a new regional representative.
"An independent chemist is defined in the PSNC constitution as a chemist operating retail pharmacy businesses' from no more than nine premises in England from which
NHS Pharmaceutical Services or Local Pharmaceutical Services are provided and a person who is not a member of the Association of Independent Multiple pharmacies
(AIMp)," said PSNC.
The following PSNC briefing sets out the election process and the actions required by those seeking to stand for election.
The Royal Pharmaceutical Society (RPS) has revealed the "differential attainment" gap among Black pharmacy students and Foundation trainees.
Research conducted by pharmacy education has revealed unique challenges leading to lower attainment in the registration assessment and an undergraduate awards
gap compared to white students.
The organisation plans to work with new groups including BPSA, GPhC, NHS England, Pharmacy Schools Council and representatives from Schools of Pharmacy, to achieve
a fair and equitable education and training experience for the students.
They plan to reach out to student representative organisations to secure their participation in a quarterly meeting of the group.
Differential attainment is the unexplained variation between groups who share a protected characteristic, for example, ethnicity, gender and disability.
The Department of Health and Social Care (DHSC) announced that free COVID-19 lateral flow tests will be supplied through community pharmacies for at-risk groups.
The service will operate from 6 November for patients aged over 12 years who are at risk of developing severe COVID-19 symptoms.
Community pharmacies that have participated in this new initiative will be paid £4 plus VAT for each box of five lateral flow device test kits provided.
Alastair Buxton, Director of NHS services at Community Pharmacy England said: "This is not going to be a high-volume service, but community pharmacy teams
are well placed to provide LFD test kits to eligible patients with them having made over 25.5 million supplies of COVID-19 LFD test kits in 2021/22.
Speaking at the SIGMA Conference 2023, Dr Leyla Hannbeck, CEO of the Association of Independent Multiple Pharmacies (AIMp), spoke about the increasing
number of prescriptions, lack of funding and other existing challenges.
Leyla explained how the pharmacy sector is facing immense challenges which are disrupting the delivery of services as well as impacting its growth.
She further spoke about the hub and spoke model, and how it is unable to solve the issues.
"Community pharmacies are clogged with prescription volume, and this is preventing them from supporting the wider NHS as well as offering services," she said.
She said that the prescription volumes have rocketed, while the number of pharmacies in England has declined from 11, 522 in the year 2021-22 to 11, 414 in 2022-23.
When it comes to Company Chemists' Association (CCA) pharmacies, there has been a loss of 1055 branches from 2022 to 2023.
Community pharmacy teams in England have broken all previous records by a distance and delivered nearly five million flu jabs in the past season.
They have administered over 2.08 million more flu vaccinations under the national programme during 2021-22 than the previous year, which is a a 75 increase, the
Pharmaceutical Services Negotiating Committee has reported.
According to latest data published by the NHS Business Services Authority in its Advanced Service Flu report community pharmacy has administered 4.85 million
vaccinations under the national Flu Vaccination Service in 2021-22.
The total number of vaccines administered in community pharmacies in 2020-21 was 2.77 million.
Commenting on the end-of-season figures, PSNC chief executive Janet Morrison said: "I am thoroughly impressed to hear it confirmed that community pharmacy has
had another record-breaking year of flu vaccination provision. The ability of pharmacy teams to deliver the healthcare services that communities need, despite
the challenges and pressures this winter, is simply phenomenal.
The Pharmaceutical Services Negotiating Committee (PSNC) has shared materials to help community pharmacy in communicating relevant advice to people during
this heatwave.
The UK Health Security Agency (UKHSA) has issued a heat-health alert for the next few days. It has also published a beat the heat poster, along with its heatwave
guidance, which could be used in pharmacies to raise awareness.
"During this heatwave, the public may turn to community pharmacy teams for advice about staying well during the hot weather or to seek assistance when feeling
unwell because of the heat," PSNC said.
It has previously developed materials that may be used by community pharmacy teams to communicate relevant messages contained in the Heatwave Plan for England
and the NHS website guidance on how to cope in hot weather.
Two pharmacies in Rotherham are set to merge into one, if plans are approved by NHS England.
Weldricks Pharmacy has applied to merge its two Swinton branches, on Church Street and the Crown Street Surgery.
If approved, the branch on Church Street will be modernised, and additional consulting rooms will be added, while the Crown Street site will be closed.
Rotherham Met Borough Council's health and wellbeing board are set to make a representation supporting the plans, and say that analysis by public health "outlines
the very minimal impact that this change will have in terms of pharmacy access in the borough based on the service offer, opening hours and walking times to this
branch and the main pharmacy."
They say the current opening hours will remain the same, and there will be no disruption to services during the consolidation.
A statement from Weldricks adds that the decision to merge is down to funding cuts, and the company could go out of business if operating costs are not reduced -
'despite having been a local, family-owned business for almost 100 years'.
Department of Health and Social Care (DHSC) has increased the rate of discount deduction for generics from 17.52 per cent to 20 per cent.
The Drug Tariff for April 2023 will contain changes to the discount deduction arrangements for pharmacy contractors, which will include- all concession lines to be
considered as Group Items for Discount Not Deducted i.e. DND or zero discount (ZD) items; and rate of discount deduction for generics to increase from 17.52% to 20%
The Pharmaceutical Services Negotiating Committee (PSNC) and DHSC agreed on the changes for all concession lines to be considered as Group Items for Discount Not
Deducted. Therefore from 1 April 2023, a new category will be introduced into Part II of the Drug Tariff 'Drugs for which discount is not deducted'.
However, the committee had rejected the changes in the rate of discount deduction for generics. It said, "Following pressure from NHS England, Ministers have now
chosen to impose changes to the previously agreed discount deduction arrangements, which come into effect from 1 April, and will be kept under review."
The current structure of global incentives to develop new antibiotics is insufficient and requires urgent resolution revealed a new report 'Incentivising new
antibiotics' by the Office of Health Economics (OHE).
OHE analysis demonstrates that on a global level, it is estimated that an effective 10-year incentive would require £3.5bn ($4.2bn) to adequately cover the entire
research and development process for a new antibiotic.
The report considers how health systems in the UK and around the world can stimulate the research and development (R&D) of new antibiotics.
In 2020, the National Institute for Health and Care Excellence (NICE) and NHS England initiated an Antimicrobial Resistance pilot with the aim of incentivising
pharmaceutical companies to develop new antibiotics by addressing the issues associated with reimbursement, which historically has deterred companies from pursuing
AMR research.
he Healthcare Distribution Association (HDA) and the Pharmaceutical Services Negotiation Committee (PSNC) have urged the NHS England and the Department of
Health and Social Care (DHSC) to issue urgent communications requesting that all those involved in medicines supply do not hoard, stockpile or over-prescribe Strep
A antibiotics.
In a statement HDA said that the sudden spike in demand for antibiotics used for the treatment of Strep A has meant that there is not enough of these medicines in
the supply chain currently to meet this increased demand. As a result, wholesalers are working extremely hard with manufacturers to increase the supply of antibiotics.
It added: "As regards pricing, the prices charged to pharmacies by HDA wholesale distributors will directly reflect the increase in prices wholesalers are having
to pay for these medicines from manufacturers at the moment, in order to be able to continue supplying these medicines to pharmacies. This will be the case until
supply and demand are more in sync."
Our Totton branch has an incredibly high volume of original pack dispensing, roughly 45,000 items. As we became busier and busier in the dispensary we were
finding that our pharmacists, dispensers and other technicians simply didn't have capacity to deliver the services that we needed them to.
We all know there is a real emphasis right now on pharmacies doing more services and we knew we had to change the way we operate to survive. So we decided it was
time to look into a sound automation solution for our medication dispensing process, one that would allow us to free up the time of the pharmacists and the rest of
the team so they could better support patients.
After a lot of research we invested in Centred Solutions FLOWRx Hub and InStore solutions which were installed late last year. It provides us with the whole package
and has automated our entire dispensing process from picking to packing and labeling to checking.
Our situation was quite unique as we bought the system initially for our existing high-volume pharmacy in Totton so the hub and the spoke are actually on the same
site. People wouldn't usually look at a hub and spoke solution for that kind of set up but it has allowed us to significantly free up time in store for more services.
What it has also done is allow us to look at other opportunities to grow and expand. The pharmacy landscape is changing and there are lots of opportunities coming up.
We have found that having your technology and the right infrastructure in place to support your existing footprint before you expand is the ideal way to grow in a
safe and controlled way.
We never thought that five years ago we would buy another pharmacy, yet we have already bought one and are now in the process of buying two more. I'm not worried
about the increase in volume this expansion will bring because I know our technology is going to be able to support it.
The pharmacies we are buying are struggling but having our solution already in place m
With the Pharmacy First services scheduled for launch end of this month, legislators explored the potential of community pharmacies to offer specific
diagnostic and treatment services in the second public evidence session of pharmacy inquiry this week (January 16).
The new service, which will enable pharmacists to offer advice and prescribe treatment for seven minor ailments, is expected to alleviate the pressure on the
NHS, reduce GP workload, and cut waiting lists.
But MPs and healthcare leaders also acknowledged that there's hesitancy and the mindset of 'GP first, not Pharmacy First' among members of the public.
"We must accept that many patients are used to seeing their GP as their first port of call for many health conditions. Pharmacy First is welcome, but there are
going to be some restrictions on how quickly some patients will want to take up some of those services, rather than seeing their GP," said William Pett, Head
of Policy, Public Affairs and Research, Healthwatch England.
A full CPE Committee Meeting was organised in London on April 17 and 18, 2024, to discuss crucial sectoral issues.
Key topics discussed during the two-day meeting included intolerable pressures on pharmacy owners, the ongoing Community Pharmacy Contractual Framework (CPCF)
negotiations, implementation of the Pharmacy First service, and governance changes.
Committee Members reviewed the progress of CPCF negotiations with the Department of Health and Social Care (DHSC) and NHS England. These critical negotiations
are being led by the Negotiating Team (NT), which includes independent pharmacy owners and representatives of CCA and non-CCA multiples.
The CPE has been advocating for an uplift to the core global sum, margin write-offs, an agreed mechanism for regular funding increases linked to activity and
inflation, annual uplifts to service fees, more fundamental reform of the margin delivery framework and an economic review of the medicines supply chain.
The Committee also discussed the results of the 2024 Pharmacy Pressures Survey, which was conducted during March and April.
Online vape store GoSmokeFree analysed data from NHS Stop Smoking Service in England from April to September 2023 to determine the number of individuals
in each of the nine UK regions who reported successfully quitting smoking after setting a quit date.
The findings showed that the South East has the highest number of successful quitters, with 1,226 smokers per 100,000 reporting to have given it up.
The Isle of Wight is the most successful area to quit smoking in the South East with 3,124 people quitting per 100,000 smokers.
Of the 4,294 individuals who set a quit date in this region, 803 admitted to not being able to achieve their target.
A spokesperson from the online retailer noted that overcoming nicotine withdrawals and mental challenges can be exceptionally difficult when attempting to quit
smoking.
In a bid to bolster the educational experience for undergraduate pharmacy students across London, Kingston University has embarked on a groundbreaking
project in collaboration with University College London and King's College London.
This initiative, fueled by a substantial £1.5 million investment from National Health Services England (NHSE), aims to elevate the quality and consistency of
pharmacy placements throughout the capital for new pharmacy entrants.
The project is designed to address the evolving standards set forth by the General Pharmaceutical Council (GphC), ensuring that newly-trained pharmacists
are well-prepared to meet the demands of their profession.
By standardizing and expanding pharmacy placements, the three universities seek to provide students with a comprehensive and diverse range of "experiential
learning opportunities".
Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been tasked to evaluate the impact, safety and effectiveness of the
Pharmacy First service, which was launched across England in January 2024.
They have been awarded £2.4million by the National Institute for Health and Care Research (NIHR) to generate evidence on the new service that allows
pharmacies to provide advice and treatment for seven common conditions without the need for a GP appointment.
After consultation, if necessary, a community pharmacist can supply some prescription-only medicines to treat earache, sore throat, sinusitis, impetigo,
shingles, infected insect bites or uncomplicated urinary tract infections in women.
The LSHTM researcher team will be working together with experts at the UK Health Security Agency (UKHSA) and the Universities of Oxford, Manchester and
Nottingham on the project.
Dr Rebecca Glover, assistant professor in Antimicrobial Resistance at LSHTM, who will lead the three-year project, said they will evaluate "Pharmacy First's
impact on GPs and the wider NHS, pharmacy services and patients."
Despite the government's announcement on lifting most Covid-19 related restrictions from next Thursday (January 27), people working in community pharmacies
will be required to adhere to the UK Health Security Agency's infection prevention control (IPC) guidance.
The ambit the guidance, which aims to protect everyone against the infection, also covers GP practices, dental practices and optometry practices, the Pharmaceutical
Services Negotiating Committee said in an update.
The negotiators also urged community pharmacy teams to encourage patients to wear a face covering while vising pharmacy to keep staff and other patients safe.
Prime minister Boris Johnson announced on Wednesday (January 19) that Covid-19 restrictions re-imposed in England last month would be lifted by from next Thursday
(January 27).
More than a third of pharmacists who participated in a survey said they have seen an increase in patients declining prescriptions due to the cost in the
last 12 months.
The survey was jointly conducted by the Pharmacists' Defence Association (PDA) and the Royal Pharmaceutical Society (RPS), extending their support for the
Prescription Charges Coalition (PCC).
Responding to the survey, 90 per cent of pharmacists admitted seeing cases where patients decline all the medicines on a prescription due to cost.
Nearly all respondents said they have seen cases where patients declined some of their prescribed medicines and more than a quarter of them have experienced
such situation often.
They have warned of the impact of prescription charges as patients are denying vital medicines, including those for blood pressure and mental health, inhalers,
antibiotics, pain relief, and statins, which can have potential consequences for the individual's health.
The Health Select Committee Expert Panel has concluded in its report published on Tuesday (25 July) that the funding aspect in the community pharmacy sector
'requires improvement' based on the evidence received.
The Expert Panel reviewed nine Government commitments, seven of which were from the Community Pharmacy Contractual Framework.
It was found that available funding was not sufficient to keep pharmacies open, struggling financially with increased demand for dispensing, workforce pressures
and rising costs due to inflation. One of the other commitments requiring improvement covered a scheme intended to protect access to local physical NHS pharmaceutical
services in areas where there were fewer pharmacies.
Professor Dame Jane Dacre, Chair of the Expert Panel, said: "Pharmacy plays a key role in the delivery of care so it's disappointing that progress overall to
deliver on the Government's commitments was rated as 'requires improvement'.